“Tirbanibulin Ointment 1%, a Novel Inhibitor of Tubulin Polymerization and Src Kinase Signaling , for the Treatment of Actinic Keratosis (AK): Results from Two Pivotal Phase III Studies”, J of Skin, vol. 4, no. 5, p. s63, Sep. 2020, doi: 10.25251/skin.4.supp.62.